Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)
Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –
Medpace operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Medpace's operating cash flow for the twelve months ending Sep 30, 2026 was $723.05M, up 1.7% year over year. For fiscal 2025 it was $713.22M, up 17.1% from the year before. Over ten years it grew 23.6% a year on average. The highest annual figure on record is $713.22M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $713.22M | +17.1% |
| FY2024 | Dec 31, 2024 | $608.82M | +40.5% |
| FY2023 | Dec 31, 2023 | $433.37M | +11.7% |
| FY2022 | Dec 31, 2022 | $388.05M | +47.4% |
| FY2021 | Dec 31, 2021 | $263.33M | +1.8% |
| FY2020 | Dec 31, 2020 | $258.68M | +28.1% |
| FY2019 | Dec 31, 2019 | $201.87M | +28.9% |
| FY2018 | Dec 31, 2018 | $156.58M | +60.8% |
| FY2017 | Dec 31, 2017 | $97.39M | +6.2% |
| FY2016 | Dec 31, 2016 | $91.73M | +6.8% |
| FY2015 | Dec 31, 2015 | $85.87M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $216.60M | -12.0% |
| Q2 FY2026 | Jun 30, 2026 | $162.01M | +9.1% |
| Q1 FY2026 | Mar 31, 2026 | $151.79M | +20.6% |
| Q4 FY2025 | Dec 31, 2025 | $192.65M | +1.0% |
| Q3 FY2025 | Sep 30, 2025 | $246.21M | +65.2% |
| Q2 FY2025 | Jun 30, 2025 | $148.53M | +27.6% |
| Q1 FY2025 | Mar 31, 2025 | $125.84M | -17.6% |
| Q4 FY2024 | Dec 31, 2024 | $190.67M | +21.9% |
| Q3 FY2024 | Sep 30, 2024 | $149.08M | +30.3% |
| Q2 FY2024 | Jun 30, 2024 | $116.40M | +41.1% |
| Q1 FY2024 | Mar 31, 2024 | $152.68M | +90.7% |
| Q4 FY2023 | Dec 31, 2023 | $156.40M | +14.4% |
| Q3 FY2023 | Sep 30, 2023 | $114.39M | +5.4% |
| Q2 FY2023 | Jun 30, 2023 | $82.52M | -14.6% |
| Q1 FY2023 | Mar 31, 2023 | $80.08M | +73.1% |
| Q4 FY2022 | Dec 31, 2022 | $136.68M | +92.8% |
| Q3 FY2022 | Sep 30, 2022 | $108.49M | +49.9% |
| Q2 FY2022 | Jun 30, 2022 | $96.62M | +53.9% |
| Q1 FY2022 | Mar 31, 2022 | $46.26M | -19.3% |
| Q4 FY2021 | Dec 31, 2021 | $70.89M | -32.8% |
| Q3 FY2021 | Sep 30, 2021 | $72.35M | +21.1% |
| Q2 FY2021 | Jun 30, 2021 | $62.76M | +41.8% |
| Q1 FY2021 | Mar 31, 2021 | $57.32M | +16.6% |
| Q4 FY2020 | Dec 31, 2020 | $105.50M | +85.3% |
| Q3 FY2020 | Sep 30, 2020 | $59.76M | -7.0% |
| Q2 FY2020 | Jun 30, 2020 | $44.27M | -5.1% |
| Q1 FY2020 | Mar 31, 2020 | $49.15M | +44.5% |
| Q4 FY2019 | Dec 31, 2019 | $56.94M | +44.4% |
| Q3 FY2019 | Sep 30, 2019 | $64.29M | +22.5% |
| Q2 FY2019 | Jun 30, 2019 | $46.63M | +12.8% |
| Q1 FY2019 | Mar 31, 2019 | $34.01M | +46.0% |
| Q4 FY2018 | Dec 31, 2018 | $39.44M | +37.7% |
| Q3 FY2018 | Sep 30, 2018 | $52.50M | +34.6% |
| Q2 FY2018 | Jun 30, 2018 | $41.34M | +36.0% |
| Q1 FY2018 | Mar 31, 2018 | $23.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $28.65M | -1.4% |
| Q3 FY2017 | Sep 30, 2017 | $39.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $30.41M | – |
| Q1 FY2017 | Mar 31, 2017 | -$675.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $29.07M | – |
See a number that looks wrong?